8-KLeadership ChangesShareholder MattersExhibits & Filings

WELLTOWER INC. 8-K Report, Executive Changes (May 7, 2012)

Filed May 7, 2012For Securities:WELL

Summary

Health Care REIT, Inc. (now Welltower Inc.) filed an 8-K on May 7, 2012, primarily reporting on its annual shareholder meeting held on May 3, 2012. The company announced the appointment of Judith C. Pelham to its Board of Directors, filling a vacancy and bringing her expertise to the Investment and Planning Committees. This appointment was accompanied by a standard indemnification agreement for directors. The filing also detailed the voting results from the annual meeting. Shareholders overwhelmingly re-elected all ten director nominees, indicating strong support for the existing board. Additionally, the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2012 was ratified with a very high majority. However, the advisory vote on executive compensation received a lower approval rate, with a significant percentage voting against it, which may warrant further investor attention.

Key Highlights

  • 1Appointment of Judith C. Pelham to the Board of Directors, effective May 3, 2012.
  • 2Ms. Pelham will serve on the Investment and Planning Committees.
  • 3An indemnification agreement was entered into with Ms. Pelham, consistent with agreements for other directors.
  • 4All ten director nominees were re-elected at the annual shareholder meeting held on May 3, 2012.
  • 5Shareholder ratification of Ernst & Young LLP as the independent registered public accounting firm for FY2012 received strong approval.
  • 6The advisory vote on executive compensation (Say-on-Pay) passed, but with a notable number of 'Against' votes (approximately 35%).

Frequently Asked Questions

This 8-K reports on two main events: the appointment of a new director, Judith C. Pelham, to the Board of Directors and the results of Health Care REIT, Inc.'s annual shareholder meeting held on May 3, 2012, including director elections, an advisory vote on executive compensation, and the ratification of the independent auditor.

Ms. Pelham's appointment to the Board of Directors expands the board's expertise and will allow her to contribute to the company's strategic direction through her membership on the Investment and Planning Committees. This is a routine corporate governance update.

Shareholders overwhelmingly re-elected all ten director nominees and strongly ratified the appointment of Ernst & Young LLP as the independent auditor. However, the advisory vote to approve executive compensation received a less enthusiastic response, with a significant portion of votes cast against it.

While the advisory vote on executive compensation ('Say-on-Pay') technically passed, the substantial number of 'Against' votes (over 56 million votes cast against) indicates potential investor dissatisfaction with certain aspects of the executive compensation structure or amounts. Investors may wish to review the company's proxy statement for more details on executive compensation and the company's response to shareholder feedback.